Clinical Trial: Research on the Promotion and Support of Diversity, Equity, and Inclusion (DEI) at the University of Tokyo (Japan)

Tokyo, April 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061360) titled 'Research on the Promotion and Support of Diversity, Equity, and Inclusion (DEI) at the University of Tokyo' on April 23.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - The University of Tokyo

Condition: Condition - Adult Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to develop a digital tool, the "Inclusive Support System (ISS)," to dynamically assess and support the subjective states of members of the University of Tokyo in order to promote diversity, equity, and inclusion (DEI) within the university, and to evaluate its feasibility and usefulness. Basic objectives2 - Others

Intervention: Interventions/Control_1 - Research participants will enter assessment data via the Inclusive Support System (ISS) every three months and will use the system for one year. After one year, a questionnaire survey will be conducted to evaluate the usefulness of the ISS and identify areas for improvement. The study office and the Barrier-Free Promotion Office will monitor data entry status and, as needed, contact participants and recommend consultation with the Barrier-Free Promotion Office or the Academic Affairs Division.

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1) Members of the University of Tokyo with disabilities (e.g., developmental disabilities, learning disabilities, mental health conditions, hearing impairments, visual impairments, physical disabilities, or internal disabilities) who seek consultation services through the Barrier-Free Promotion Office.

2) Written informed consent has been obtained. Key exclusion criteria - None Target Size - 20

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 10 Month 28 Day Date of IRB - 2025 Year 10 Month 28 Day Anticipated trial start date - 2026 Year 05 Month 18 Day Last follow-up date - 2028 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068490

Disclaimer: Curated by HT Syndication.